Literature DB >> 18829543

Tbx3 represses E-cadherin expression and enhances melanoma invasiveness.

Mercedes Rodriguez1, Ewa Aladowicz, Luisa Lanfrancone, Colin R Goding.   

Abstract

The T-box transcription factors Tbx2 and Tbx3 are overexpressed in many cancers and in melanoma promote proliferation by actively suppressing senescence. Whether they also contribute to tumor progression via other mechanisms is not known. Here, we identify a novel role for these factors, providing evidence that Tbx3, and potentially Tbx2, directly repress the expression of E-cadherin, a keratinocyte-melanoma adhesion molecule whose loss is required for the acquisition of an invasive phenotype. Overexpression of Tbx2 and Tbx3 in melanoma cells down-regulates endogenous E-cadherin expression, whereas depletion of Tbx3, but not Tbx2, increases E-cadherin mRNA and protein levels and decreases melanoma invasiveness in vitro. Consistent with these observations, in melanoma tissue, Tbx3 and E-cadherin expression are inversely correlated. Depletion of Tbx3 also leads to substantial up-regulation of Tbx2. The results suggest that Tbx2 and Tbx3 may play a dual role during the radial to vertical growth phase transition by both inhibiting senescence via repression of p21(CIP1) expression, and enhancing melanoma invasiveness by decreasing E-cadherin levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829543     DOI: 10.1158/0008-5472.CAN-08-0301

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  71 in total

1.  Antineoplastic effects of Rhodiola crenulata treatment on B16-F10 melanoma.

Authors:  Maxine C Dudek; Kaitlyn E Wong; Lotfi M Bassa; Maria Carmen Mora; Jennifer Ser-Dolansky; Jean M Henneberry; Giovanna M Crisi; Richard B Arenas; Sallie S Schneider
Journal:  Tumour Biol       Date:  2015-07-10

2.  Epithelial-mesenchymal transition - activating transcription factors - multifunctional regulators in cancer.

Authors:  Minal Garg
Journal:  World J Stem Cells       Date:  2013-10-26       Impact factor: 5.326

3.  Phenotypic screening identifies Axl kinase as a negative regulator of an alveolar epithelial cell phenotype.

Authors:  Naoya Fujino; Hiroshi Kubo; Rose A Maciewicz
Journal:  Lab Invest       Date:  2017-05-29       Impact factor: 5.662

Review 4.  Regulation of organogenesis and stem cell properties by T-box transcription factors.

Authors:  Yasuo Takashima; Atsushi Suzuki
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 5.  Molecular pathology of cutaneous melanoma.

Authors:  Léon C van Kempen; Margaret Redpath; Caroline Robert; Alan Spatz
Journal:  Melanoma Manag       Date:  2014-12-04

6.  Microphthalmia-associated transcription factor/T-box factor-2 axis acts through Cyclin D1 to regulate melanocyte proliferation.

Authors:  L Pan; X Ma; B Wen; Z Su; X Zheng; Y Liu; H Li; Y Chen; J Wang; F Lu; J Qu; L Hou
Journal:  Cell Prolif       Date:  2015-10-21       Impact factor: 6.831

7.  Overexpression of Tbx3 is correlated with Epithelial-Mesenchymal Transition phenotype and predicts poor prognosis of colorectal cancer.

Authors:  Ze-Zhi Shan; Xue-Bing Yan; Lei-Lei Yan; Yuan Tian; Qing-Cai Meng; Wang-Wang Qiu; Zhen Zhang; Zhi-Ming Jin
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

8.  TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression.

Authors:  Xiaomeng Li; Xianhui Ruan; Peitao Zhang; Yang Yu; Ming Gao; Shukai Yuan; Zewei Zhao; Jie Yang; Li Zhao
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

9.  The transcription factors TBX2 and TBX3 interact with human papillomavirus 16 (HPV16) L2 and repress the long control region of HPVs.

Authors:  Marc A Schneider; Konstanze D Scheffer; Timo Bund; Fatima Boukhallouk; Carsten Lambert; Cristina Cotarelo; Gert O Pflugfelder; Luise Florin; Gilles A Spoden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  The retinoblastoma protein modulates Tbx2 functional specificity.

Authors:  Keith W Vance; Heather M Shaw; Mercedes Rodriguez; Sascha Ott; Colin R Goding
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.